1. Home
  2. CAC vs WGSWW Comparison

CAC vs WGSWW Comparison

Compare CAC & WGSWW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CAC
  • WGSWW
  • Stock Information
  • Founded
  • CAC 1875
  • WGSWW 2017
  • Country
  • CAC United States
  • WGSWW United States
  • Employees
  • CAC N/A
  • WGSWW N/A
  • Industry
  • CAC Major Banks
  • WGSWW Retail: Computer Software & Peripheral Equipment
  • Sector
  • CAC Finance
  • WGSWW Technology
  • Exchange
  • CAC Nasdaq
  • WGSWW Nasdaq
  • Market Cap
  • CAC N/A
  • WGSWW N/A
  • IPO Year
  • CAC 1997
  • WGSWW N/A
  • Fundamental
  • Price
  • CAC $40.47
  • WGSWW $0.21
  • Analyst Decision
  • CAC Hold
  • WGSWW
  • Analyst Count
  • CAC 3
  • WGSWW 0
  • Target Price
  • CAC $48.33
  • WGSWW N/A
  • AVG Volume (30 Days)
  • CAC 96.0K
  • WGSWW 36.6K
  • Earning Date
  • CAC 04-29-2025
  • WGSWW 02-18-2025
  • Dividend Yield
  • CAC 4.14%
  • WGSWW N/A
  • EPS Growth
  • CAC 21.89
  • WGSWW N/A
  • EPS
  • CAC 3.62
  • WGSWW N/A
  • Revenue
  • CAC $177,396,000.00
  • WGSWW $305,450,000.00
  • Revenue This Year
  • CAC $36.38
  • WGSWW N/A
  • Revenue Next Year
  • CAC $6.75
  • WGSWW N/A
  • P/E Ratio
  • CAC $11.22
  • WGSWW N/A
  • Revenue Growth
  • CAC 10.05
  • WGSWW 50.79
  • 52 Week Low
  • CAC $28.62
  • WGSWW $0.17
  • 52 Week High
  • CAC $50.07
  • WGSWW $0.21
  • Technical
  • Relative Strength Index (RSI)
  • CAC 36.39
  • WGSWW N/A
  • Support Level
  • CAC $40.80
  • WGSWW N/A
  • Resistance Level
  • CAC $42.35
  • WGSWW N/A
  • Average True Range (ATR)
  • CAC 1.03
  • WGSWW 0.00
  • MACD
  • CAC 0.02
  • WGSWW 0.00
  • Stochastic Oscillator
  • CAC 18.60
  • WGSWW 0.00

About WGSWW GeneDx Holdings Corp.

GeneDx Holdings Corp delivers personalized and actionable health insights to inform diagnosis, direct treatment and improve drug discovery. The company is uniquely positioned to accelerate the use of genomic and large-scale clinical information to enable precision medicine as the standard of care. GeneDx is at the forefront of transforming healthcare through its various exome and genome testing and interpretation, fueled by one of the world's substantial rare disease data sets.

Share on Social Networks: